Literature DB >> 15197245

Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.

Michael J Avram1, Tom C Krejcie, Thomas K Henthorn, Claus U Niemann.   

Abstract

Beta-adrenergic receptor blockers decrease intravenous anesthetic dose requirements. The present study determined the effect of propranolol on indocyanine green and antipyrine disposition from the moment of rapid intravenous injection. Anti-pyrine is a physiological marker that distributes to a volume as large as total body water in a blood flow-dependent manner and is a pharmacokinetic surrogate for many lipophilic drugs, including intravenous anesthetics. Antipyrine and indocyanine green disposition were determined twice in five healthy adult males in this Institutional Review Board-approved study, once during propranolol infusion. After rapid indocyanine green and antipyrine injection, arterial blood samples were collected frequently for 2 min and less frequently thereafter. Plasma indocyanine green and antipyrine concentrations were measured by high-performance liquid chromatography. Indocyanine green and antipyrine disposition were characterized, using SAAM II, by a recirculatory pharmacokinetic model that describes drug disposition from the moment of injection. Parameters were compared using the paired t test. The disposition of indocyanine green demonstrated that propranolol decreased cardiac output at the expense of the fast peripheral (nonsplanchnic) intravascular circuit. The area under the antipyrine concentration versus time relationship was doubled for at least the first 3 min after injection due to both decreased cardiac output and maintenance of nondistributive blood flow at the expense of a two-thirds reduction of blood flow (intercompartmental clearance) to the rapidly equilibrating (fast, splanchnic) tissue volume. The increase in antipyrine area under the curve due to propranolol-induced alteration of initial antipyrine disposition could explain decreased intravenous anesthetic dose requirements in the presence of beta-adrenergic receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197245     DOI: 10.1124/jpet.104.070094

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients.

Authors:  Michael Weiss; Marije Reekers; Jaap Vuyk; Fred Boer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-03       Impact factor: 2.745

Review 2.  Beta-adrenergic antagonists during general anesthesia reduced postoperative pain: a systematic review and a meta-analysis of randomized controlled trials.

Authors:  Lasse Härkänen; Jari Halonen; Tuomas Selander; Hannu Kokki
Journal:  J Anesth       Date:  2015-07-10       Impact factor: 2.078

3.  The effect of perioperative esmolol infusion on the postoperative nausea, vomiting and pain after laparoscopic appendectomy.

Authors:  Sang-Jun Lee; Jong-Nam Lee
Journal:  Korean J Anesthesiol       Date:  2010-09-20

4.  Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.

Authors:  Muhammad Nasir Kalam; Muhammad Fawad Rasool; Faleh Alqahtani; Imran Imran; Asim Ur Rehman; Naveed Ahmed
Journal:  Drug Des Devel Ther       Date:  2021-03-17       Impact factor: 4.162

5.  Comparison of effects of intraoperative esmolol and ketamine infusion on acute postoperative pain after remifentanil-based anesthesia in patients undergoing laparoscopic cholecystectomy.

Authors:  Mi Hyeon Lee; Mi Hwa Chung; Cheol Sig Han; Jeong Hyun Lee; Young Ryong Choi; Eun Mi Choi; Hyun Kyung Lim; Young Duk Cha
Journal:  Korean J Anesthesiol       Date:  2014-03-28

6.  Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate.

Authors:  Jonathan Grip; Tobias Falkenström; Panuwat Promsin; Jan Wernerman; Åke Norberg; Olav Rooyackers
Journal:  Crit Care       Date:  2020-02-10       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.